Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5697738 | Clinical Oncology | 2017 | 5 Pages |
Abstract
In this retrospective study we evaluated the long-term results of 35 early-stage favourable T1-2 N0 M0 anal cancer patients treated with intensity-modulated radiotherapy techniques combining low dose prophylactic inguinal-pelvic irradiation with dose-escalated boost. Optimal locoregional control and good tolerance makes this treatment a valuable alternative to brachytherapy boost and involved-field radiotherapy plans.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
L. Lestrade, T. Zilli, M. Kountouri, R. Jumeau, O. Matzinger, J. Bourhis, R. Miralbell, M. Ozsahin, B. De Bari,